Titan Pharmaceuticals's market cap is currently $3.48M. The company's EPS TTM is $-6.888; its P/E ratio is ―; Titan Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 184.00K	$ 60.00K	$ 1.53M	$ 4.84M	$ 3.61M
Gross Profit	$ 72.00K	$ -136.00K	$ 1.33M	$ 4.37M	$ 2.32M
Operating Income	$ -7.28M	$ -10.23M	$ -9.35M	$ -7.35M	$ -16.84M
EBITDA	$ -7.17M	$ -10.04M	$ -9.13M	$ -7.06M	$ -6.28M
Net Income	$ -5.57M	$ -10.18M	$ -8.11M	$ -20.73M	$ -16.09M
Balance Sheet
Cash & Short-Term Investments	$ 6.76M	$ 2.94M	$ 6.04M	$ 5.41M	$ 5.22M
Total Assets	$ 8.09M	$ 4.06M	$ 7.99M	$ 8.09M	$ 9.52M
Total Debt	$ 565.00K	$ 187.00K	$ 299.00K	$ 809.00K	$ 4.44M
Net Debt	$ -6.20M	$ -2.75M	$ -5.74M	$ -4.60M	$ -782.00K
Total Liabilities	$ 1.44M	$ 2.69M	$ 2.86M	$ 4.55M	$ 8.09M
Stockholders' Equity	$ 6.64M	$ 1.36M	$ 5.14M	$ 3.53M	$ 1.43M
Cash Flow
Free Cash Flow	$ -7.09M	$ -8.18M	$ -7.92M	$ -17.74M	$ -15.70M
Operating Cash Flow	$ -7.09M	$ -8.18M	$ -7.90M	$ -17.20M	$ -15.45M
Investing Cash Flow	$ 732.00K	$ 0.00	$ -23.00K	$ -540.00K	$ -256.00K
Financing Cash Flow	$ 10.00M	$ 4.98M	$ 8.84M	$ 17.93M	$ 11.27M

Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

Income Statement >

Titan Pharmaceuticals Debt to Assets

Balance Sheet >

Titan Pharmaceuticals Cash Flow

Cash Flow >

Titan Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing